全文获取类型
收费全文 | 7351篇 |
免费 | 461篇 |
国内免费 | 229篇 |
专业分类
耳鼻咽喉 | 85篇 |
儿科学 | 127篇 |
妇产科学 | 18篇 |
基础医学 | 561篇 |
口腔科学 | 15篇 |
临床医学 | 779篇 |
内科学 | 2297篇 |
皮肤病学 | 36篇 |
神经病学 | 250篇 |
特种医学 | 74篇 |
外科学 | 1194篇 |
综合类 | 801篇 |
预防医学 | 386篇 |
眼科学 | 58篇 |
药学 | 1097篇 |
5篇 | |
中国医学 | 154篇 |
肿瘤学 | 104篇 |
出版年
2024年 | 8篇 |
2023年 | 134篇 |
2022年 | 193篇 |
2021年 | 334篇 |
2020年 | 298篇 |
2019年 | 281篇 |
2018年 | 300篇 |
2017年 | 231篇 |
2016年 | 184篇 |
2015年 | 256篇 |
2014年 | 544篇 |
2013年 | 585篇 |
2012年 | 478篇 |
2011年 | 485篇 |
2010年 | 394篇 |
2009年 | 368篇 |
2008年 | 319篇 |
2007年 | 351篇 |
2006年 | 321篇 |
2005年 | 229篇 |
2004年 | 188篇 |
2003年 | 195篇 |
2002年 | 178篇 |
2001年 | 140篇 |
2000年 | 140篇 |
1999年 | 111篇 |
1998年 | 81篇 |
1997年 | 102篇 |
1996年 | 70篇 |
1995年 | 65篇 |
1994年 | 50篇 |
1993年 | 50篇 |
1992年 | 33篇 |
1991年 | 24篇 |
1990年 | 22篇 |
1989年 | 26篇 |
1988年 | 25篇 |
1987年 | 31篇 |
1986年 | 21篇 |
1985年 | 26篇 |
1984年 | 23篇 |
1983年 | 16篇 |
1982年 | 23篇 |
1981年 | 24篇 |
1980年 | 22篇 |
1979年 | 11篇 |
1978年 | 15篇 |
1977年 | 9篇 |
1976年 | 9篇 |
1974年 | 6篇 |
排序方式: 共有8041条查询结果,搜索用时 31 毫秒
1.
2.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
3.
4.
5.
6.
7.
《Biomaterials》2015
Bacterial infection of subcutaneous “pockets” housing cardiovascular implantable electronic devices is a significant clinical complication. In this study, pacemakers encapsulated in a blood plasma-based material (PBM) composited with antibiotics were investigated for use as prophylactics against such infections. PBMs, which are made from pooled allogeneic plasma and platelets, are off-the-shelf biomaterials that can be manufactured in the form of complex 3D shapes, extrudable putties, or injectable pastes. In vitro studies with PBM pastes formulated with rifampicin and minocycline demonstrated antibiotic release over 6 days, activity against Escherichia coli, and reduced cytotoxic effects of the antibiotics on fibroblasts. The materials were also evaluated in vivo in a rabbit model in which pacemaker pockets were inoculated with methicillin-resistant Staphylococcus aureus (S. aureus) strain and examined 1 week later. The pockets containing the pacemaker plus S. aureus were grossly purulent and culture positive, whereas pockets into which PBM with antibiotics were injected around the pacemaker were free of purulence and culture negative (p < 0.001). None of the pockets into which PBM without antibiotics were placed demonstrated purulence, but 60% were culture positive. These results demonstrate the potential of PBMs to deliver antibiotics to diminish the incidence of pocket infections for pacemakers and other implantable devices. 相似文献
8.
9.
Ramya Deepthi Vinnakota Allan S. Brett 《The American journal of the medical sciences》2019,357(2):160-163
Iron deficiency anemia is often listed among potential adverse effects of gastric acid-suppressive medications, given that gastric acidity promotes intestinal absorption of nonheme iron. Additionally, the antacid calcium carbonate can inhibit iron absorption. However, there is little direct clinical evidence that proton-pump inhibitors, histamine-2 receptor antagonists, or calcium carbonate cause iron deficiency anemia. Most case reports have had substantial limitations (e.g., minimal follow-up and presence of other causes of iron deficiency), and retrospective cohort studies have lacked sufficient patient-specific detail to make strong causal inferences. We present 2 cases—both with detailed, prospective 10-year follow-up—in which combinations of proton-pump inhibitors, histamine-2 receptor antagonists and calcium carbonate were clearly associated with development of iron deficiency anemia. Overt iron-deficiency anemia is probably uncommon in patients who use acid-modifying medications and who have no other conditions that predispose to iron deficiency. Nevertheless, clinicians should be aware of this potential complication, given widespread use of these agents. 相似文献
10.